They work by: Helping regulate blood sugar Slowing digestion Reducing appetite Supporting weight loss Improving insulin response Today, they are commonly prescribed for: Type 2 diabetes Obesity Heart disease risk reduction Weight management Popular GLP-1 medications include: Ozempic Wegovy Mounjaro Zepbound Rybelsus Why GLP-1 Medications Matter for Kidney Patients Kidney disease and diabetes are closely connected
GLP-1 receptor agonists, like semaglutide and tirzepatide, could be a game-changer in reducing cardiovascular disease in this vulnerable group
Endotronix has received investigational device exemption (IDE) approval from the US Food and Drug Administration (FDA) for a subsequent multicentre study, PROACTIVE-HF 2, which will evaluate the company's Cordella sensor for pulmonary artery (PA) pressure-guided therapy
"In 2023, it is estimated that 500,000 people consumed one of these drugs in the US, and it is estimated that it could reach up to 15 million American adults by 2030
For two of these drugs, risperidone and venlafaxine, the active metabolites (paliperidone and desvenlafaxine, respectively) were marketed as drugs in their own right several years after the parent drugs were marketed
Research suggests that people with compromised kidney function often have lower levels of circulating glutathione
